Skip to content
← Full study record

NCT00691015 · MORE INFO

Limitations, agreements, and source contact

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant · Source last updated 2017-06-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
zalkadh@emory.edu
organization
Barbara Ann Karmanos Institute
phone
(404) 778-1900
title
Zaid Al-Kadhimi, M. D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
zalkadh@emory.edu
organization
Barbara Ann Karmanos Institute
phone
(404) 778-1900
title
Zaid Al-Kadhimi, M. D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice